Firms
LSI Zeta
LSI Zeta is Life Science Invest’s sixth Nordic life-science co-investment company. It pools capital from business angels with biotechnology, medical technology and entrepreneurial experience to invest in early-stage Nordic life sciences, health technology and medical technology companies. The vehicle announced EUR2.9 million raised from 35 angels in January 2026 and aims to build a portfolio of around ten companies, supporting them with expertise as well as financing. Published investments include CubaseBio, Mesenkia Therapeutics, Solid IO, StemSight and RAB Diagnostics. It is a distinct investing vehicle under the Life Science Invest network; its published angel shareholders are members and investors rather than employees.
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
Operations and support
Co-investing
Leo Capital
Solid IO$— · 2026-06-23
Investments
| $—2026-06-25 |  StemSight | LSI Zeta |
| $—2026-06-23 | Solid IO | Leo Capital, LSI Zeta |
| $—2026-05-22 |  Mesenkia Therapeutics | LSI Zeta |